84 related articles for article (PubMed ID: 2639616)
1. [Preoperative levels of CA 125 and risk factors in adenocarcinoma of the endometrium].
Marcello C; Corda F; Pilloni MD; Puligheddu P; Lecca U
Ann Ostet Ginecol Med Perinat; 1989; 110(6):290-5. PubMed ID: 2639616
[TBL] [Abstract][Full Text] [Related]
2. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
Tseng PC; Sprance HE; Carcangiu ML; Chambers JT; Schwartz PE
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum CA-125 levels in treating endometrial cancer.
Powell JL; Hill KA; Shiro BC; Diehl SJ; Gajewski WH
J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.
Berchuck A; Soisson AP; Clarke-Pearson DL; Soper JT; Boyer CM; Kinney RB; McCarty KS; Bast RC
Cancer Res; 1989 Apr; 49(8):2091-5. PubMed ID: 2702650
[TBL] [Abstract][Full Text] [Related]
6. Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis.
Tsai CC; Liu YS; Huang EY; Huang SC; Chang HW; Tseng CW; ChangChien CC
Gynecol Oncol; 2006 Mar; 100(3):591-5. PubMed ID: 16290001
[TBL] [Abstract][Full Text] [Related]
7. The role of the preoperative serum carcinoembryonic antigen level in early-stage adenocarcinoma of the uterine cervix.
Tsai CC; Lin H; Huang EY; Huang SC; Hsieh CH; Chang SY; Chien CC
Gynecol Oncol; 2004 Aug; 94(2):363-7. PubMed ID: 15297173
[TBL] [Abstract][Full Text] [Related]
8. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.
Boronow RC; Morrow CP; Creasman WT; Disaia PJ; Silverberg SG; Miller A; Blessing JA
Obstet Gynecol; 1984 Jun; 63(6):825-32. PubMed ID: 6728365
[TBL] [Abstract][Full Text] [Related]
9. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
[TBL] [Abstract][Full Text] [Related]
10. Tumor antigens CA 125 and CA 15-3 as markers of endometrial adenocarcinoma.
Babilonti L; Riccardi A; Tateo S; Pavesi F; Lotzniker M; Polatti F
J Nucl Med Allied Sci; 1990; 34(4 Suppl):79-83. PubMed ID: 2092155
[No Abstract] [Full Text] [Related]
11. Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma.
Scambia G; Gadducci A; Panici PB; Foti E; Ferdeghini M; Ferrandina G; Amoroso M; Castellani C; Facchini V; Mancuso S
Gynecol Oncol; 1994 Sep; 54(3):292-7. PubMed ID: 8088605
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer.
Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Carone MD; Aloe S; Tedesco M; Mancini R; Casale V; Carlini S; Casciani CU; Roselli M; Guadagni F
Anticancer Res; 1999; 19(2B):1363-8. PubMed ID: 10365107
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative platelet count as index of the grading in endometrial carcinoma].
Giannella L; Menozzi G; Di Monte I; Venturini P; De Pace V; Boselli F; Ternelli G; Jasonni VM
Minerva Ginecol; 2008 Aug; 60(4):273-9. PubMed ID: 18560341
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
15. [CA-125 antigen in patients with cancer of the uterine body].
Gisterek M; Wawrzkiewicz M; Kornafel J
Wiad Lek; 1990 Sep 1-15; 43(17-18):866-9. PubMed ID: 2278143
[TBL] [Abstract][Full Text] [Related]
16. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
18. Biochemical prognostic factors and risk of relapses in patients with cervical cancer.
Gadducci A; Tana R; Fanucchi A; Genazzani AR
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S23-6. PubMed ID: 17727924
[TBL] [Abstract][Full Text] [Related]
19. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
20. Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma.
Rose PG; Sommers RM; Reale FR; Hunter RE; Fournier L; Nelson BE
Obstet Gynecol; 1994 Jul; 84(1):12-6. PubMed ID: 8008305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]